Diabetes and Chronic Heart Failure: From Diabetic Cardiomyopathy to Therapeutic Approach

被引：0

作者：

Dei Cas, A. ^{[1
]}

Spigoni, V. ^{[2
]}

Ridolfi, V. ^{[1
]}

Metra, M. ^{[2
]}

机构：

[1] Univ Parma, Unit Diabet & Prevent Associated Dis, Dept Clin & Expt Med, I-43100 Parma, Italy

[2] Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Brescia, Italy

来源：

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS | 2013年 / 13卷 / 01期

关键词：

Chronic heart failure; diabetes mellitus; diabetic cardiomyopathy; molecular mechanisms; structural alteration; therapy; GLUCAGON-LIKE PEPTIDE-1; GLYCATION END-PRODUCTS; SARCOPLASMIC-RETICULUM CA2+-ATPASE; VENTRICULAR DIASTOLIC DYSFUNCTION; PRESERVED EJECTION FRACTION; TISSUE GROWTH-FACTOR; KINASE-C ISOFORMS; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Diabetes and chronic heart failure are interrelated conditions with major medical and economic impact that have to be treated as a distinct entity. Several pathological mechanisms have been investigated and proposed to explain the structural and functional changes associated with diabetic cardiomyopathy. These mechanisms are likely to act synergically and may potentiate one the other. This review outlines recent advances in the pathophysiological mechanisms implicated in the development and progression of diabetic cardiomyopathy and in current therapeutic strategies.

引用

页码：38 / 50

页数：13

共 50 条

[1] Current status on the therapeutic strategies for heart failure and diabetic cardiomyopathy
Kim, Amy Hyein
Jang, Jung Eun
Han, Jin
[J]. BIOMEDICINE & PHARMACOTHERAPY, 2022, 145
[2] CHRONIC HEART-FAILURE - THERAPEUTIC APPROACH
ERDMANN, E
[J]. MEDIZINISCHE WELT, 1989, 40 (11): : 318 - 322
[3] Diabetes-Related Heart Failure - Does Diabetic Cardiomyopathy Exist?
Bando, Yasuko K.
Murohara, Toyoaki
[J]. CIRCULATION JOURNAL, 2014, 78 (03) : 576 - 583
[4] Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus
Nakamura, Kazufumi
Miyoshi, Toru
Yoshida, Masashi
Akagi, Satoshi
Saito, Yukihiro
Ejiri, Kentaro
Matsuo, Naoaki
Ichikawa, Keishi
Iwasaki, Keiichiro
Naito, Takanori
Namba, Yusuke
Yoshida, Masatoki
Sugiyama, Hiroki
Ito, Hiroshi
[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
[5] Cardiomyopathy and heart failure in diabetes
Tang, WHW
Young, JB
[J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2001, 30 (04) : 1031 - +
[6] Testosterone: A Novel Therapeutic Approach in Chronic Heart Failure?
Aukrust, Pal
Ueland, Thor
Gullestad, Lars
Yndestad, Arne
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (10) : 928 - 929
[7] Right Ventricular Function in Chronic Heart Failure: From the Diagnosis to the Therapeutic Approach
Monitillo, Francesco
Di Terlizzi, Vito
Gioia, Margherita Ilaria
Barone, Roberta
Grande, Dario
Parisi, Giuseppe
Brunetti, Natale Daniele
Iacoviello, Massimo
[J]. JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2020, 7 (02)
[8] Heart failure in chronic chagasic cardiomyopathy
Cursack, Guillermo
Maidana, Griselda
Manfredi, Carlos
Huerta, Clara Maria
Cimbaro Canella, Juan Pablo
Josefina Blanchet, Maria
Lorena Coronel, Maria
Perna, Eduardo
Aguinaga, Luis
Nunez, Cristian
Alvarez, Moira
Pablo Escalante, Juan
Cecilia Moris, Maria
Garcia Brasca, Daniela
Lobo Marquez, Lilia Luz
[J]. INSUFICIENCIA CARDIACA, 2019, 14 (01) : 12 - 33
[9] Therapeutic Applications of Cannabinoids in Cardiomyopathy and Heart Failure
Garza-Cervantes, J. A.
Ramos-Gonzalez, M.
Lozano, O.
Jerjes-Sanchez, C.
Garcia-Rivas, G.
[J]. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
[10] The Mitochondria in Diabetic Heart Failure: From Pathogenesis to Therapeutic Promise
Schilling, Joel D.
[J]. ANTIOXIDANTS & REDOX SIGNALING, 2015, 22 (17) : 1515 - 1526

← 1 2 3 4 5 →